Global Overactive Bladder Treatment Market Research Report 2012-2024
- HEY3239142
- 86 Pages
- July 2019
- Medical Devices
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
The global Overactive Bladder Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Anticholinergics
Mirabegron
Botox
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Anticholinergics
1.2.1.2 Mirabegron
1.2.1.3 Botox
1.2.2 by Application
1.2.2.1 Idiopathic Overactive Bladder
1.2.2.2 Neurogenic Overactive Bladder
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Anticholinergics Market, 2013-2018
4.1.2 Mirabegron Market, 2013-2018
4.1.3 Botox Market, 2013-2018
4.2 Market Forecast
4.2.1 Anticholinergics Market Forecast, 2019-2024
4.2.2 Mirabegron Market Forecast, 2019-2024
4.2.3 Botox Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Idiopathic Overactive Bladder Market, 2013-2018
5.1.2 Neurogenic Overactive Bladder Market, 2013-2018
5.2 Market Forecast
5.2.1 Idiopathic Overactive Bladder Market Forecast, 2019-2024
5.2.2 Neurogenic Overactive Bladder Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Astellas Pharma
8.2 Allergan
8.3 Pfizer
8.4 Teva (Activas)
8.5 Johnson & Johnson
9 Conclusion
Table Products Segment of Overactive Bladder Treatment
Table Anticholinergics Overview
Table Mirabegron Overview
Table Botox Overview
Table Global Overactive Bladder Treatment Market by Type, 2011-2022 (USD Million)
Table Application Segment of Overactive Bladder Treatment
Table Idiopathic Overactive Bladder Overview
Table Neurogenic Overactive Bladder Overview
Table Global Overactive Bladder Treatment Market by Application, 2011-2022 (USD Million)
Table Global Overactive Bladder Treatment Market by Region, 2011-2022 (USD Million)
Table Cost of Overactive Bladder Treatment
Table Market Dynamics
Table Policy of Overactive Bladder Treatment
Table GDP of Major Countries
Table Anticholinergics CAGR by Revenue and Volume, 2012-2018
Table Mirabegron CAGR by Revenue and Volume, 2012-2018
Table Botox CAGR by Revenue and Volume, 2012-2018
Table Anticholinergics CAGR by Revenue and Volume, 2012-2024
Table Mirabegron CAGR by Revenue and Volume, 2012-2024
Table Botox CAGR by Revenue and Volume, 2012-2024
Table Idiopathic Overactive Bladder CAGR by Revenue and Volume, 2012-2018
Table Neurogenic Overactive Bladder CAGR by Revenue and Volume, 2012-2018
Table Global Overactive Bladder Treatment Market by Vendors, 2012-2018 (USD Million)
Table Global Overactive Bladder Treatment Market by Vendors, 2012-2018 (in Volume)
Table Global Overactive Bladder Treatment Market Share by Vendors, 2012-2018 (USD Million)
Table Global Overactive Bladder Treatment Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Astellas Pharma Profile List
Table Microecological Modulator Operating Data of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Profile List
Table Microecological Modulator Operating Data of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva (Activas) Profile List
Table Microecological Modulator Operating Data of Teva (Activas) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
